4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-17-053880
Director sold 5,000 shares at $21.97 ($109,850)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lingnau Lutz Director | 2017-09-22 | Sale | −5,000 | $21.97 | $109,850 | 27,450 | D: show line 1 in the form |
| Open-market sales · 5,000 sh · avg $21.97 · $109,850 | |||||||
Loading xslF345X03/doc4.xml…